|4Jun 5, 4:45 PM ET

CytoDyn Inc. 4

4 · CytoDyn Inc. · Filed Jun 5, 2017

Insider Transaction Report

Form 4
Period: 2017-06-01
Transactions
  • Award

    Stock Options (right to buy)

    2017-06-01+75,00075,000 total
    Exercise: $0.57Exp: 2027-06-01Common Stock (75,000 underlying)
  • Award

    Stock Options (right to buy)

    2017-06-01+600,000600,000 total
    Exercise: $0.57Exp: 2027-06-01Common Stock (600,000 underlying)
Footnotes (2)
  • [F1]Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, the options will vest in four equal quarterly installments commencing on September 1, 2017.
  • [F2]Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, one third of the options will vest on each date that is six months, 18 months and 30 months following the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION